
Fluidigm Corporation FLDM
Fluidigm Corporation ROCE Ratio 2011-2025 | FLDM
Annual ROCE Ratio Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -18.87 | -22.35 | -18.1 | -22.99 | -26.43 | -15.88 | -10.88 | -17.57 | -17.69 | -26.31 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -10.88 | -26.43 | -19.71 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-17.75 | $ 18.87 | -2.58 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 20.7 | -3.99 % | $ 221 M | ||
|
Co-Diagnostics
CODX
|
-47.68 | $ 0.23 | -2.51 % | $ 6.75 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
1.9 | $ 39.31 | -0.22 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
9.82 | $ 230.56 | 0.1 % | $ 169 B | ||
|
BioNano Genomics
BNGO
|
-293.94 | $ 1.51 | -0.79 % | $ 1.92 M | ||
|
DarioHealth Corp.
DRIO
|
-66.97 | $ 10.22 | 1.79 % | $ 290 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
-36.48 | $ 101.59 | 0.01 % | $ 18.8 B | ||
|
DexCom
DXCM
|
28.89 | $ 67.6 | 0.04 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-6.52 | $ 26.68 | -0.15 % | $ 807 M | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-77.82 | $ 19.05 | -2.21 % | $ 1.02 B | ||
|
Celcuity
CELC
|
-97.97 | $ 101.08 | -1.15 % | $ 3.99 B | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-69.16 | $ 3.2 | - | $ 102 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
36.29 | $ 226.35 | -0.25 % | $ 41 B | ||
|
Guardant Health
GH
|
317.65 | $ 101.82 | -1.13 % | $ 12.5 B | ||
|
Myriad Genetics
MYGN
|
-17.62 | $ 6.37 | -1.77 % | $ 577 M | ||
|
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | ||
|
ENDRA Life Sciences
NDRA
|
-281.17 | $ 4.94 | -1.0 % | $ 2.65 M | ||
|
Neogen Corporation
NEOG
|
-51.22 | $ 7.21 | 1.05 % | $ 1.56 B | ||
|
National Research Corporation
NRC
|
81.8 | $ 18.67 | 0.06 % | $ 458 M | ||
|
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.24 | 0.48 % | $ 20 B | ||
|
Personalis
PSNL
|
-33.64 | $ 8.04 | -1.23 % | $ 476 M | ||
|
Illumina
ILMN
|
-35.1 | $ 133.85 | -0.81 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
6.57 | $ 203.33 | -0.16 % | $ 10.4 B | ||
|
Quidel Corporation
QDEL
|
69.35 | $ 29.16 | -0.48 % | $ 1.23 B | ||
|
RadNet
RDNT
|
11.59 | $ 72.97 | -0.24 % | $ 5.33 B | ||
|
Soleno Therapeutics
SLNO
|
-76.57 | $ 47.75 | 0.2 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 175.26 | -0.39 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
-41.6 | $ 6.8 | -0.29 % | $ 882 M | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 253.22 | -0.29 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 182.86 | 0.01 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
50.7 | $ 682.93 | -0.81 % | $ 56.3 B | ||
|
Lantheus Holdings
LNTH
|
42.0 | $ 66.88 | 0.25 % | $ 4.63 B | ||
|
Mettler-Toledo International
MTD
|
35.8 | $ 1 413.97 | -0.43 % | $ 30 B |